Zyter Virtual Rounding: HIPAA Compliant, Cloud-based Telehealth Solution That Enables Physicians to Conduct Virtual Hospital Rounds: Increases Safety During COVID-19 Pandemic

Zyter Virtual Rounding solution features multi-party video chat, that makes it possible for nurses, residents, medical students, and even the patient’s family members to remotely and safely participate in virtual visits in COVID-19 wards and all other hospital units.

More than a secure video chat platform, Zyter Virtual Rounding integrates with the hospital’s electronic health record (EHR) system to give physicians and care teams real-time access to the patient’s EHR within the Zyter solution’s context-aware video chat as they conduct the virtual visit. As a result, physicians and nurses have the patient’s medical history, test results, medications, and more, instantly at their fingertips to help them provide prompt, more informed care during rounds. Hospital residents and medical students accompanying physicians on virtual rounds also benefit from the learning experience of having a comprehensive view of each patient’s case.

Physicians have the flexibility to conduct virtual rounding in two ways – physically in the patient’s room while using Zyter Virtual Rounding on a tablet while the care team attends virtually, or remotely from the physician’s office or any other location. In the latter scenario, a clinician at the hospital will place a tablet with Zyter Virtual Rounding on a stand at the patient’s bedside for the patient to use during the virtual visit. The physician initiates a virtual visit on Zyter Virtual Rounding by clicking on a patient’s hospital room number. The patient, the care team, and the patient’s family members all receive notification of the virtual visit via email or SMS messaging so they can connect and participate.

Using Zyter Virtual Rounding, hospitals can improve clinical workflow and patient care while enhancing the safety of physicians and patients during rounds, especially during the current COVID-19 pandemic. Another benefit of Zyter Virtual Rounding is the potential cost savings on personal protective equipment (PPE) by reducing the number of care team members who are physically present in the patient’ room. For example, only the physician in the room requires PPE, while the six or more residents or medical students attending remotely through the application do not. 

“Zyter Virtual Rounding is a game changer as it enables physicians and others to not only see the patient, but also see every detail of that patient’s medical record during a video chat call,” said Sanjay Govil, founder and CEO of Zyter, Inc. “By bringing in more data, the quality of care during virtual rounds can increase because physicians have a complete, holistic view of their patients and conditions.”

Zyter Virtual Rounding easily scales up to any number of participants and can be securely accessed through a browser on any iOS or Android digital tablet or mobile device with a cellular or Internet connection. Zyter Virtual Rounding can also be integrated with other telehealth solutions such as in-home visits, patient device monitoring, and remote patient monitoring.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.